Loading
IARC estimates 1,078 new cancer cases and 642 cancer deaths in Eswatini in 2024; the commonest new cancers are cervix uteri, prostate and breast. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 414 | 76.5 | Cervical cancer |
| Prostate | 107 | 35.6 | Prostate cancer |
| Breast | 95 | 18.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Kaposi sarcoma | 50 | 4.1 | Kaposi sarcoma |
| Trachea, bronchus and lung | 40 | 5.0 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 40 | 4.3 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 39 | 4.4 | Hepatocellular carcinoma |
| Non-Hodgkin lymphoma | 29 | 2.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 27 | 2.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Vulva | 26 | 4.5 | Vulvar cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 235 | 44.3 | Cervical cancer |
| Prostate | 64 | 21.6 | Prostate cancer |
| Breast | 56 | 11.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 38 | 4.8 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Liver and intrahepatic bile ducts | 37 | 4.2 | Hepatocellular carcinoma |
| Leukaemia | 26 | 2.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Colorectum | 23 | 2.8 | Colorectal cancer |
| Kaposi sarcoma | 19 | 1.5 | Kaposi sarcoma |
| Non-Hodgkin lymphoma | 14 | 1.7 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Oesophagus | 11 | 1.4 | Oesophageal cancer |
No trial record in OnCo lists a site in Eswatini. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Eswatini.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Eswatini is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Eswatini is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.